Enspryng 120 mg/mL prefilled syringe Images

Generic Name: satralizumab

This medication has been identified as Enspryng 120 mg/mL prefilled syringe. It is supplied by Genentech, Inc.

Enspryng is used in the treatment of Neuromyelitis Optica Spectrum Disorder and belongs to the drug class interleukin inhibitors. Enspryng 120 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Enspryng

Generic Name

satralizumab

Strength

120 mg/mL prefilled syringe

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0007

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer